SCHRODER INVESTMENT MANAGEMENT GROUP - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$534,000
-50.2%
151,608
-5.9%
0.00%0.0%
Q4 2021$1,073,000
-31.1%
161,173
+3.2%
0.00%
-50.0%
Q3 2021$1,558,000
-69.2%
156,136
-4.7%
0.00%
-66.7%
Q2 2021$5,058,000
+10.9%
163,755
+56.7%
0.01%0.0%
Q1 2021$4,559,000
-57.6%
104,497
-55.0%
0.01%
-25.0%
Q4 2020$10,754,000232,0740.01%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders